New frontiers in multiple myeloma: Ciltacabtagene autoleucel, a BCMA-directed CAR-T therapy
Cilta-cel ( Ciltacabtagene autoleucel ) is an investigational BCMA-directed CAR-T therapy in development for the treatment of adults with relapsed and/or refractory multiple myeloma.
CAR‑T therapy is ...
read article